Drug profile · INN
caspofungin
CANCIDAS (PREVIOUSLY CASPOFUNGIN MSD)
caspofungin (CANCIDAS (PREVIOUSLY CASPOFUNGIN MSD)) is an FDA-listed pharmaceutical active ingredient.
EMA: approved NMPA: clinical trials Antiinfectives for systemic use (J02) J02AX04
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — caspofungin
- Class
- Antiinfectives for systemic use (J02)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.83
Quick answer
caspofungin (CANCIDAS (PREVIOUSLY CASPOFUNGIN MSD)) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN caspofungin
Brand CANCIDAS (PREVIOUSLY CASPOFUNGIN MSD)
Therapeutic class Antiinfectives for systemic use (J02)
ATC code J02AX04
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is caspofungin?
caspofungin (CANCIDAS (PREVIOUSLY CASPOFUNGIN MSD)) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for caspofungin?
CANCIDAS (PREVIOUSLY CASPOFUNGIN MSD) is a marketed brand name for caspofungin. Check FDA Drugs@FDA for the current US label holder and prescribing information.